421 related articles for article (PubMed ID: 9710347)
1. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
2. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
3. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
[TBL] [Abstract][Full Text] [Related]
4. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
[TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
7. Effects of dialysis membrane on intradialytic vancomycin administration.
Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
9. [Vancomycin dosing in hemodialysis patients].
Castellano I; González Castillo PM; Covarsí A; Martínez Sánchez J; Suárez Santisteban MA; Gallego S; Marigliano N
Nefrologia; 2008; 28(6):607-12. PubMed ID: 19016633
[TBL] [Abstract][Full Text] [Related]
10. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
[TBL] [Abstract][Full Text] [Related]
12. Subtherapeutic serum vancomycin concentrations during on-line hemodiafiltration.
Sombolos KI; Fragidis SK; Bamichas GI; Hatsiou VN; Rizos AK; Natse TA; Fytili CI
ASAIO J; 2011; 57(6):507-10. PubMed ID: 21946313
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
Rodríguez N; Gómez M; Rico N; María Campistol J; Maduell F
Artif Organs; 2019 Mar; 43(3):261-269. PubMed ID: 30302764
[TBL] [Abstract][Full Text] [Related]
15. Effect of hemodialysis on ceftazidime pharmacokinetics.
Nikolaidis P; Tourkantonis A
Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
[TBL] [Abstract][Full Text] [Related]
18. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
Barth RH; DeVincenzo N
Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
[TBL] [Abstract][Full Text] [Related]
19. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
Teigen MM; Duffull S; Dang L; Johnson DW
J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
[TBL] [Abstract][Full Text] [Related]
20. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.
Kielstein JT; Eugbers C; Bode-Boeger SM; Martens-Lobenhoffer J; Haller H; Joukhadar C; Traunmüller F; Knitsch W; Hafer C; Burkhardt O
Nephrol Dial Transplant; 2010 May; 25(5):1537-41. PubMed ID: 20031929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
